• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted?

作者信息

Yohanathan Lavanya

机构信息

Corewell East William Beaumont University Hospital, Royal Oak, MI, USA.

出版信息

Ann Surg Oncol. 2024 Jul;31(7):4173-4175. doi: 10.1245/s10434-024-15253-5. Epub 2024 Apr 28.

DOI:10.1245/s10434-024-15253-5
PMID:38679677
Abstract
摘要

相似文献

1
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted?复发性肝内胆管癌是否值得再次手术切除？
Ann Surg Oncol. 2024 Jul;31(7):4173-4175. doi: 10.1245/s10434-024-15253-5. Epub 2024 Apr 28.
2
Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.再次手术治疗肝内胆管细胞癌患者首次肝切除术后复发的效果。
Int J Clin Oncol. 2020 Dec;25(12):2083-2089. doi: 10.1007/s10147-020-01775-x. Epub 2020 Aug 31.
3
First and repeat liver resection for primary and recurrent intrahepatic cholangiocarcinoma.原发性和复发性肝内胆管癌的初次及再次肝切除术
Am J Surg. 2016 Aug;212(2):221-9. doi: 10.1016/j.amjsurg.2015.07.016. Epub 2015 Oct 3.
4
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis.再次肝切除术治疗复发性肝内胆管细胞癌是否合理？国际分析的结果。
Ann Surg Oncol. 2024 Jul;31(7):4397-4404. doi: 10.1245/s10434-024-14975-w. Epub 2024 Feb 9.
5
Predicting Recurrence Patterns Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.预测肝内胆管癌根治性切除术后的复发模式
Ann Surg Oncol. 2023 Mar;30(3):1282-1284. doi: 10.1245/s10434-022-12833-1. Epub 2022 Nov 22.
6
Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.复发性肝内胆管癌患者再次肝切除的有效性：与长期预后相关的因素
Surgery. 2017 Apr;161(4):897-908. doi: 10.1016/j.surg.2016.10.024. Epub 2016 Dec 16.
7
Liver resection for recurrent hilar cholangiocarcinoma.复发性肝门部胆管癌的肝切除术
Br J Surg. 1993 Nov;80(11):1433. doi: 10.1002/bjs.1800801127.
8
Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.肝切除治疗原发性和复发性肝内胆管细胞癌的预后。
BJS Open. 2019 Sep 10;3(6):793-801. doi: 10.1002/bjs5.50217. eCollection 2019 Dec.
9
Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.既往接受根治性手术切除后复发性肝内胆管癌患者的管理与结局
Ann Surg Oncol. 2016 Jan;23(1):235-43. doi: 10.1245/s10434-015-4642-9. Epub 2015 Jun 10.
10
Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.肝内胆管细胞癌：44 例连续切除病例分析，其中 5 例为重复切除。
Am J Surg. 2011 Feb;201(2):203-8. doi: 10.1016/j.amjsurg.2008.12.035. Epub 2009 May 9.

本文引用的文献

1
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis.再次肝切除术治疗复发性肝内胆管细胞癌是否合理？国际分析的结果。
Ann Surg Oncol. 2024 Jul;31(7):4397-4404. doi: 10.1245/s10434-024-14975-w. Epub 2024 Feb 9.
2
Synergistic impact of resection margin and microscopic vascular invasion for patients with HBV-related intrahepatic cholangiocarcinoma.HBV 相关肝内胆管细胞癌患者切缘和微血管侵犯的协同影响。
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):575-582. doi: 10.1080/17474124.2021.1913053. Epub 2021 Apr 25.
3
Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.
日本第20次全国原发性肝癌随访调查结果报告。
Hepatol Res. 2020 Jan;50(1):15-46. doi: 10.1111/hepr.13438. Epub 2020 Jan 5.
4
A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm.一种用于预测肝内胆管癌肝切除术后长期生存的新型在线预后工具：“地铁票”模式。
J Surg Oncol. 2019 Aug;120(2):223-230. doi: 10.1002/jso.25480. Epub 2019 Apr 19.
5
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌（BILCAP）：一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
6
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.根治性切除术后肝内胆管细胞癌早期与晚期复发。
Br J Surg. 2018 Jun;105(7):848-856. doi: 10.1002/bjs.10676. Epub 2017 Nov 28.
7
Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models.肝内胆管癌切除术后的复发模式及无病生存期：术前和术后预后模型
J Am Coll Surg. 2016 Sep;223(3):493-505.e2. doi: 10.1016/j.jamcollsurg.2016.05.019. Epub 2016 Jun 11.
8
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.可切除胆管癌：辅助治疗策略的作用综述
Clin Med Insights Oncol. 2016 May 12;10:43-8. doi: 10.4137/CMO.S32821. eCollection 2016.
9
Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.既往接受根治性手术切除后复发性肝内胆管癌患者的管理与结局
Ann Surg Oncol. 2016 Jan;23(1):235-43. doi: 10.1245/s10434-015-4642-9. Epub 2015 Jun 10.
10
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.肝内胆管癌诊断和管理指南
J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27.